44 results
6-K
EX-99.1
KMDA
Kamada Ltd
13 Jul 23
Notice of Extraordinary General Meeting of Shareholders
4:05pm
ability to access capital may be limited and the cost of raising capital may increase, and there can be no assurance of the Company’s ability
6-K
EX-99.2
5b6ukuc6i
22 Nov 21
Report of Foreign Private Issuer
7:06am
6-K
EX-99.1
kugerzdh ydk
27 Apr 20
Kamada and Kedrion Biopharma Announce Global Collaboration for the Development, Manufacturing and Polyclonal Immunoglobulin Product
7:00am
6-K
EX-99.1
ldgcjgddn
11 Mar 20
Report of Foreign Private Issuer
7:02am